Did you re­ceive a com­plete re­sponse let­ter in the past year? Now may be the time for a re­sub­mis­sion.

In the wake of FDA Com­mis­sion­er...

The FDA has is­sued a new batch of warn­ing let­ters to 25 tele­health com­pa­nies, ac­cus­ing them of mak­ing false and mis­lead­ing claims in their mar­ket­ing...

The wait­ing list at a UK on­line phar­ma­cy for No­vo Nordisk’s We­govy pill now stands at 30,000 peo­ple a week af­ter ap­proval, in a sign...

No­vo Nordisk got robbed and is in the un­en­vi­able po­si­tion of be­ing ex­tort­ed by the thieves. At stake, ac­cord­ing to a group that has claimed...

Reg­u­la­to­ry flex­i­bil­i­ty ap­pears to be back on the FDA’s menu fol­low­ing the de­par­tures of Mar­ty Makary and Vinay Prasad.

At the cen­ter of the...

For much of its first decade, Cana­di­an an­ti­body de­vel­op­er Ab­Cellera signed part­ner­ship af­ter part­ner­ship, se­cur­ing 40 bio­phar­ma al­liances that led to more than a dozen...